Gilead Sciences (LIM:GILD) FFO


LIM:GILD Gilead Sciences Inc LIM:GILD
69 GF Score
Price $131.50
GF Value $93.02
! 3 Warning Signs
View Full Analysis

What is Gilead Sciences FFO?

FFO (Funds from operations) only applies to REITs.

LIM:GILD
69GF Score
Gilead Sciences Inc LIM:GILD
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gilead Sciences (LIM:GILD) Overvalued in 2026?

Based on GuruFocus' analysis, Gilead Sciences stock appears to be overvalued. The current stock price of $131.50 is trading 41.4% above its estimated GF Value™ of $93.02.

Key valuation signals for LIM:GILD:

  • FFO:
  • GF Value™: $93.02 vs. price of $131.50 (41.4% above fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the LIM:GILD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gilead Sciences Business Description

Address 333 Lakeside Drive, Foster City, CA, USA, 94404
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
69GF Score

Get the complete analysis for LIM:GILD

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$131.50
Price
$93.02
GF Value